デジタル治療薬の市場規模、シェア、成長分析、製品別、用途別、収益モデル別、販売チャネル別、地域別 - 産業予測 2025～2032年

デジタル治療薬市場規模は2023年に65億米ドルと評価され、2024年の82億1,000万米ドルから2032年には531億5,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは26.3％で成長する見通しです。

デジタル治療薬市場は、エビデンスに基づく治療介入を提供するソフトウェアやデバイスに対する需要の急増によって、力強い成長を遂げています。これらの技術は、メンタルヘルス障害、糖尿病、呼吸器疾患、心血管疾患など、さまざまな慢性疾患の予防と管理においてヘルスケアプロバイダを支援します。糖尿病、精神疾患、がん、心不全などの慢性疾患の罹患率の増加は、市場の採用を大幅に後押ししています。また、製薬業界ではデジタル治療薬の採用が増加しており、この勢いに拍車をかけています。業界のリーダーたちは、先進的な治療法を革新するための研究開発を優先し、製品開発をさらに推進しています。これらの要素が相まって、デジタル治療薬市場の拡大が促進され、患者の治療選択肢が拡大しています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 特許分析
• 技術分析
• ケーススタディ

デジタル治療薬市場規模：提供別& CAGR（2025-2032）

• 市場概要
• ソフトウェア/プラットフォーム
• プログラム
• バーチャルリアリティ/ゲーム

デジタル治療薬市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 治療/ケア関連の用途
  • 糖尿病
  • 中枢神経系（CNS）疾患
  • 精神疾患
  • その他の中枢神経系疾患
  • 禁煙
  • 慢性呼吸器疾患
  • 筋骨格系障害
  • 心血管疾患
  • 服薬遵守
  • 胃腸障害
  • リハビリテーションと患者ケア
  • 物質使用障害と依存症管理
  • その他の治療/ケア関連の用途
• 予防的用途
  • 前糖尿病
  • 肥満
  • 栄養
  • ライフスタイル管理
  • その他の予防的応用

デジタル治療薬市場規模：収益モデル別& CAGR（2025-2032）

• 市場概要
• サブスクリプションモデル
• ワンタイム購入/年間ライセンシングモデル
• 成果/価値ベースモデル

デジタル治療薬市場規模：販売チャネル別& CAGR（2025-2032）

• 市場概要
• B2B販売チャネル
  • 支払者
  • 雇用主
  • 製薬会社
  • プロバイダー
  • その他の購入者
• B2C販売チャネル
  • 介護者
  • 患者

デジタル治療薬市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024年）

主要企業プロファイル

• Dassault Systemes（SIMULIA）（France）
• Siemens Digital Industries Software（Simcenter）（Germany）
• PTC（Creo）（US）
• Autodesk（Simulation）（US）
• OpenFOAM（Open-source）（N/A）
• STAR-CCM+（US/Germany）
• COMSOL Multiphysics（Sweden）
• ESI Group（France）
• MathWorks（MATLAB/Simulink）（US）
• Flow3D（US）
• Cadence Design Systems（US）
• Synopsys（US）
• Pointwise（US）

結論と提言

Digital Therapeutics Market size was valued at USD 6.5 billion in 2023 and is poised to grow from USD 8.21 billion in 2024 to USD 53.15 billion by 2032, growing at a CAGR of 26.3% during the forecast period (2025-2032).

The digital therapeutics market is experiencing robust growth, driven by a surge in demand for software and devices that offer evidence-based therapeutic interventions. These technologies assist healthcare providers in the prevention and management of various chronic diseases, including mental health disorders, diabetes, respiratory conditions, and cardiovascular issues. Rising incidences of chronic illnesses such as diabetes, mental health disorders, cancer, and heart failure are significantly boosting market adoption. Additionally, the pharmaceutical sector's increasing embrace of digital therapeutics is contributing to this momentum. Industry leaders are prioritizing research and development to innovate advanced therapies, further propelling product development. Collectively, these elements are fostering the expansion of the digital therapeutics market and enhancing treatment options for patients.

Top-down and bottom-up approaches were used to estimate and validate the size of the Digital Therapeutics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Digital Therapeutics Market Segments Analysis

Global Digital Therapeutics Market is segmented by Offering, Application, Revenue Model, Sales Channel and region. Based on Offering, the market is segmented into Software/Platforms, Programs and Virtual Reality/Games. Based on Application, the market is segmented into Treatment/Care-Related Applications and Preventive Applications. Based on Revenue Model, the market is segmented into Subscription-Based Model, One-Time Purchase/Annual Licensing Model and Outcome /Value-Based Model. Based on Sales Channel, the market is segmented into B2B Sales Channel and B2C Sales Channel. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Digital Therapeutics Market

The Digital Therapeutics market is being significantly driven by the rising demand for software and devices aimed at managing and treating chronic diseases worldwide. With a growing prevalence of chronic conditions, including type 1 and type 2 diabetes, various cancers, Alzheimer's disease, obesity, and gastrointestinal disorders, the need for innovative therapeutic solutions is becoming increasingly critical. This trend is particularly notable in emerging economies, where the demand for effective digital health interventions is surging. As more people seek accessible and efficient management options for these chronic conditions, the digital therapeutics sector is poised for substantial growth throughout the forecast period.

Restraints in the Digital Therapeutics Market

The Digital Therapeutics market, characterized by its innovative software and device-driven products designed to prevent, manage, or treat various medical conditions, faces significant challenges that hinder its growth. Increasing concerns over cybersecurity threaten to impede the widespread adoption of these therapeutics, as patients grow increasingly aware of the potential risks to their personal medical data. Additionally, regulatory uncertainties, complications with reimbursement processes, and unequal access to technology further complicate the landscape, limiting the market's expansion. As these issues continue to unfold, they contribute to a restrained environment for digital therapeutics in the healthcare ecosystem.

Market Trends of the Digital Therapeutics Market

The integration of digital therapeutics with healthcare systems marks a significant trend in the market, reflecting a shift towards more accessible and efficient patient care. By seamlessly connecting digital therapeutic solutions with electronic health records (EHRs) and other healthcare platforms, providers can enhance real-time data access and monitoring capabilities, ultimately facilitating informed clinical decision-making. This integration not only boosts operational efficiencies and patient outcomes but also strengthens data security and standardization in information sharing. As healthcare continues to embrace technology, the demand for digital therapeutics that align with existing healthcare infrastructures is poised to grow, driving innovation and investment in this pivotal sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Patent Analysis
• Technology Analysis
• Case Studies

Global Digital Therapeutics Market Size by Offering & CAGR (2025-2032)

• Market Overview
• Software/Platforms
• Programs
• Virtual Reality/Games

Global Digital Therapeutics Market Size by Application & CAGR (2025-2032)

• Market Overview
• Treatment/Care-Related Applications
  • Diabetes
  • Central Nervous System (CNS) Disorders
  • Mental health disorders
  • Other CNS disorders
  • Smoking Cessation
  • Chronic Respiratory Diseases
  • Musculoskeletal Disorders
  • Cardiovascular Diseases
  • Medication Adherence
  • Gastrointestinal Disorders
  • Rehabilitation & Patient Care
  • Substance Use Disorders & Addiction Management
  • Other Treatment/Care-Related Applications
• Preventive Applications
  • Prediabetes
  • Obesity
  • Nutrition
  • Lifestyle Management
  • Other Preventive Applications

Global Digital Therapeutics Market Size by Revenue Model & CAGR (2025-2032)

• Market Overview
• Subscription-Based Model
• One-Time Purchase/Annual Licensing Model
• Outcome /Value-Based Model

Global Digital Therapeutics Market Size by Sales Channel & CAGR (2025-2032)

• Market Overview
• B2B Sales Channel
  • Payers
  • Employers
  • Pharmaceutical Companies
  • Providers
  • Other Buyers
• B2C Sales Channel
  • Caregivers
  • Patients

Global Digital Therapeutics Market Size & CAGR (2025-2032)

• North America (Offering, Application, Revenue Model, Sales Channel)
  • US
  • Canada
• Europe (Offering, Application, Revenue Model, Sales Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Offering, Application, Revenue Model, Sales Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Offering, Application, Revenue Model, Sales Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Offering, Application, Revenue Model, Sales Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Dassault Systemes (SIMULIA) (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Digital Industries Software (Simcenter) (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PTC (Creo) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Autodesk (Simulation) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OpenFOAM (Open-source) (N/A)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• STAR-CCM+ (US/Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• COMSOL Multiphysics (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ESI Group (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MathWorks (MATLAB/Simulink) (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Flow3D (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cadence Design Systems (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synopsys (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pointwise (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations